Post-Conference Perspectives: Recent Advances in the Management of Chronic GvHD - Episode 1

The Chronic GvHD Landscape: Risk Factors and Diagnosis

July 19, 2023

Preet M. Chaudhary, MD, PhD, Noah Merin, MD, PhD

Preet M. Chaudhary, MD, PhD and Noah Merin, MD, PhD review how chronic GvHD is diagnosed, the different types of chronic GvHD, and key risk factors for the disease.

Now Viewing

EP. 1: The Chronic GvHD Landscape: Risk Factors and Diagnosis

EP. 2: First-line Treatment for Patients with Chronic GvHD

EP. 3: Defining and Managing Steroid Refractory Chronic GvHD

EP. 4: Role of Ruxolitinib in Steroid-Refractory Chronic GvHD

EP. 5: Understanding Mechanisms of Action: Ruxolitinib, Ibrutinib, and Belumosudil

EP. 6: Key Efficacy Data of Ibrutinib and Belumosudil in Steroid-Refractory Chronic GvHD Patients

EP. 7: Real World Data on the Use of Ruxolitinib and Treatment Selection in chronic GvHD

EP. 8: Future Directions in Chronic GvHD